Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 119 articles: HTML format Text format

Single Articles

March 2010
1. BERTHIER A , Seguin S, Sasco AJ, Bobin JY, et al
   High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. GRAHAM K , de Las Morenas A, Tripathi A, King C, et al
   Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. SOVA H , Jukkola-Vuorinen A, Puistola U, Kauppila S, et al
   8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. BRAY J , Sludden J, Griffin MJ, Cole M, et al
   Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SUTHERLAND S , Ashley S, Miles D, Chan S, et al
   Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases - the UK experience.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ROYER B , Yin W, Pegram M, Ibrahim N, et al
   Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. NEVILLE-WEBBE HL , Coleman RE, Holen I
   Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. NEWCOMB PA , Trentham-Dietz A, Hampton JM
   Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. NAKANISHI T , Chumsri S, Khakpour N, Brodie AH, et al
   Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling.
   Br J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SANDSTROM RE
    Regarding: Koilocytes indicate a role for human papilloma virus in breast cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
11. GELARDI T , Damiano V, Rosa R, Bianco R, et al
    Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.
    Br J Cancer. 2010;102:513-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
12. HAMAOKA T , Costelloe CM, Madewell JE, Liu P, et al
    Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BAKER L , Quinlan PR, Patten N, Ashfield A, et al
    p53 mutation, deprivation and poor prognosis in primary breast cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. HADJI P , Ziller M, Albert US, Kalder M, et al
    Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BUFFA FM , Harris AL, West CM, Miller CJ, et al
    Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
    Br J Cancer. 2010;102:428-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. THOMAS J , Evans A, Macartney J, Pinder SE, et al
    Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project.
    Br J Cancer. 2010;102:285-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. STENGEL C , Newman SP, Leese MP, Potter BV, et al
    Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents.
    Br J Cancer. 2010;102:316-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. RUIZ-GARCIA E , Scott V, Machavoine C, Bidart JM, et al
    Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CHO E , Holmes MD, Hankinson SE, Willett WC, et al
    Choline and betaine intake and risk of breast cancer among post-menopausal women.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
20. MUNKACSY G , Abdul-Ghani R, Mihaly Z, Tegze B, et al
    PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. NALWOGA H , Arnes JB, Wabinga H, Akslen LA, et al
    Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. CHEN J , Imanaka N, Chen J, Griffin JD, et al
    Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. JOHNSON N , Bentley J, Wang LZ, Newell DR, et al
    Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MUROHASHI M , Hinohara K, Kuroda M, Isagawa T, et al
    Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LINSELL L , Forbes LJ, Kapari M, Burgess C, et al
    A randomised controlled trial of an intervention to promote early presentation of breast cancer in older women: effect on breast cancer awareness.
    Br J Cancer. 2009;101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. JERNSTROM H , Bageman E, Rose C, Jonsson PE, et al
    CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.
    Br J Cancer. 2009;101:1817-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. VAN DER AUWERA I , Peeters D, Benoy IH, Elst HJ, et al
    Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
28. BERRINGTON DE GONZALEZ A , Curtis RE, Gilbert E, Berg CD, et al
    Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. DROST RM , Jonkers J
    Preclinical mouse models for BRCA1-associated breast cancer.
    Br J Cancer. 2009;101:1651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. RUBINO C , Arriagada R, Delaloge S, Le MG, et al
    Relation of risk of contralateral breast cancer to the interval since the first primary tumour.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BOUGNOUX P , Hajjaji N, Ferrasson MN, Giraudeau B, et al
    Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. OSORIO A , Milne RL, Pita G, Peterlongo P, et al
    Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. DOSE-SCHWARZ J , Tiling R, Avril-Sassen S, Mahner S, et al
    Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. BRANDT A , Bermejo JL, Sundquist J, Hemminki K, et al
    Age of onset in familial breast cancer as background data for medical surveillance.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. VAN AGTHOVEN T , Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, et al
    CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. BARRETT T , Bowden DJ, Greenberg DC, Brown CH, et al
    Radiological staging in breast cancer: which asymptomatic patients to image and how.
    Br J Cancer. 2009;101:1522-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. MEGO M , De Giorgi U, Broglio K, Dawood S, et al
    Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
38. SCRIVEN P , Coulson S, Haines R, Balasubramanian S, et al
    Activation and clinical significance of the unfolded protein response in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. BORDONI A , Probst-Hensch NM, Mazzucchelli L, Spitale A, et al
    Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. GANAI S , Arenas RB, Forbes NS
    Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. CASTRO F , Leal B, Denny A, Bahar R, et al
    Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer.
    Br J Cancer. 2009;101:1329-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. TOI M , Iwata H, Fujiwara Y, Ito Y, et al
    Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LUNDGREN K , Nordenskjold B, Landberg G
    Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. HIRATA T , Shimizu C, Yonemori K, Hirakawa A, et al
    Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. YAN M , Rayoo M, Takano EA, Thorne H, et al
    BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.
    Br J Cancer. 2009;101:1168-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
46. LAWSON JS , Glenn WK, Heng B, Ye Y, et al
    Koilocytes indicate a role for human papilloma virus in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. LIM LY , Vidnovic N, Ellisen LW, Leong CO, et al
    Mutant p53 mediates survival of breast cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MARTINEZ-CAMPA C , Gonzalez A, Mediavilla MD, Alonso-Gonzalez C, et al
    Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. FLAGENG MH , Haugan Moi LL, Dixon JM, Geisler J, et al
    Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. VERMEULEN PB , Van Laere SJ, Dirix LY
    Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intravascular growth.
    Br J Cancer. 2009;101:1028-9.
    PubMed     Text format     Related articles   
    
    
    
51. HUGHES-DAVIES L , Caldas C, Wishart GC
    Tamoxifen: the drug that came in from the cold.
    Br J Cancer. 2009;101:875-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. KAUPPILA A , Kyyronen P, Hinkula M, Pukkala E, et al
    Birth intervals and breast cancer risk.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. HENG B , Glenn WK, Ye Y, Tran B, et al
    Human papilloma virus is associated with breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. CAMPBELL HE , Taylor MA, Harris AL, Gray AM, et al
    An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. VERRILL M
    Chemotherapy for early-stage breast cancer: a brief history.
    Br J Cancer. 2009;101 Suppl 1:S2-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. TRUEMAN P
    Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review.
    Br J Cancer. 2009;101 Suppl 1:S15-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. JONES AL , Leonard R
    Breast cancer: Improved care through effective management of febrile neutropenia. Foreword.
    Br J Cancer. 2009;101 Suppl 1:S1.
    PubMed     Text format     Related articles   
    
    
    August 2009
58. SINILNIKOVA OM , Antoniou AC, Simard J, Healey S, et al
    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. BONEBERG EM , Legler DF, Hoefer MM, Ohlschlegel C, et al
    Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer.
    Br J Cancer. 2009;101:605-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. HOWELL SJ , Searle C, Goode V, Gardener T, et al
    The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
    Br J Cancer. 2009;101:582-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. KOSCIELNY S , Arriagada R, Adolfsson J, Fornander T, et al
    Impact of tumour size on axillary involvement and distant dissemination in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. TALVINEN K , Karra H, Hurme S, Nykanen M, et al
    Securin promotes the identification of favourable outcome in invasive breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. GRELIER G , Voirin N, Ay AS, Cox DG, et al
    Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.
    Br J Cancer. 2009;101:673-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. BLUFF JE , Menakuru SR, Cross SS, Higham SE, et al
    Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.
    Br J Cancer. 2009;101:666-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
65. PARK Y , Okamura K, Mitsuyama S, Saito T, et al
    Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. DASKALAKI A , Agelaki S, Perraki M, Apostolaki S, et al
    Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. TANTELES GA , Whitworth J, Mills J, Peat I, et al
    Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer?
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. BATES T , Kearins O, Monypenny I, Lagord C, et al
    Clinical outcome data for symptomatic breast cancer: the breast cancer clinical outcome measures (BCCOM) project.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. TUBIANA-MATHIEU N , Bougnoux P, Becquart D, Chan A, et al
    All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. CHARPIN C , Giusiano S, Charfi S, Secq V, et al
    Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome.
    Br J Cancer. 2009;101:48-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. ZHANG H , Zeng X, Li Q, Gaillard-Kelly M, et al
    Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore.
    Br J Cancer. 2009;101:71-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
72. RASUL S , Balasubramanian R, Filipovic A, Slade MJ, et al
    Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells.
    Br J Cancer. 2009;100:1879-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. RYAN AJ , Napoletano S, Fitzpatrick PA, Currid CA, et al
    Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. BRITTON P , Duffy SW, Sinnatamby R, Wallis MG, et al
    One-stop diagnostic breast clinics: how often are breast cancers missed?
    Br J Cancer. 2009;100:1873-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. FERRUCCI LM , Cross AJ, Graubard BI, Brinton LA, et al
    Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. LOUSSOUARN D , Campion L, Leclair F, Campone M, et al
    Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. PICHOT CS , Hartig SM, Xia L, Arvanitis C, et al
    Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. WIDSCHWENDTER M , Lichtenberg-Frate H, Hasenbrink G, Schwarzer S, et al
    Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. ARMAOU S , Pertesi M, Fostira F, Thodi G, et al
    Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. AZZATO EM , Greenberg D, Shah M, Blows F, et al
    Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?
    Br J Cancer. 2009;100:1806-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
81. SHAH R , Smith P, Purdie C, Quinlan P, et al
    The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.
    Br J Cancer. 2009;100:1687-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. LAGIOU P , Hsieh CC, Lipworth L, Samoli E, et al
    Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. HALL PS , Rautenberg TA, McCabe C
    Cost analysis for cancer subgroups.
    Br J Cancer. 2009;100:1513.
    PubMed     Text format     Related articles   
    
    
    
84. GRONWALD J , Cybulski C, Piesiak W, Suchy J, et al
    Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.
    Br J Cancer. 2009;100:1508-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. RUMJAHN SM , Yokdang N, Baldwin KA, Thai J, et al
    Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis.
    Br J Cancer. 2009;100:1465-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
86. VAN DER AUWERA I , Elst HJ, Van Laere SJ, Maes H, et al
    The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.
    Br J Cancer. 2009;100:1277-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. ROSENBERG L , Czene K, Hall P
    Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. CHANG-CLAUDE J , Ambrosone CB, Lilla C, Kropp S, et al
    Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. COLEMAN LJ , Peter MB, Teall TJ, Brannan RA, et al
    Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. OLSEN AH , Bihrmann K, Jensen MB, Vejborg I, et al
    Breast density and outcome of mammography screening: a cohort study.
    Br J Cancer. 2009;100:1205-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. BENNETT RL , Blanks RG, Moss SM
    Evaluation of extension of breast screening to women aged 65-70 in England using screening performance measures.
    Br J Cancer. 2009;100:1043-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. CUTULI B , Lemanski C, Fourquet A, de Lafontan B, et al
    Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.
    Br J Cancer. 2009;100:1048-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
93. VELENTZIS LS , Cantwell MM, Cardwell C, Keshtgar MR, et al
    Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. AALTONEN K , Amini RM, Heikkila P, Aittomaki K, et al
    High cyclin B1 expression is associated with poor survival in breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. NILSSON G , Holmberg L, Garmo H, Terent A, et al
    Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke.
    Br J Cancer. 2009;100:811-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. JONES AL , Barlow M, Barrett-Lee PJ, Canney PA, et al
    Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.
    Br J Cancer. 2009;100:684-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. HORLOCK C , Stott B, Dyson PJ, Morishita M, et al
    The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer.
    Br J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. UMEMURA S , Shirane M, Takekoshi S, Kusakabe T, et al
    Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.
    Br J Cancer. 2009;100:764-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
99. THOMAS RJ , Williams M, Marshall C, Glen J, et al
    The total hospital and community UK costs of managing patients with relapsed breast cancer.
    Br J Cancer. 2009;100:598-600.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. WU MH , Chou YC, Chou WY, Hsu GC, et al
     Circulating levels of leptin, adiposity and breast cancer risk.
     Br J Cancer. 2009;100:578-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. PARK YH , Park MJ, Ji SH, Yi SY, et al
     Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. LODDO M , Kingsbury SR, Rashid M, Proctor I, et al
     Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. LOPERGOLO A , Pennati M, Gandellini P, Orlotti NI, et al
     Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. BROWN SB , Mallon EA, Edwards J, Campbell FM, et al
     Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. TOVEY SM , Brown S, Doughty JC, Mallon EA, et al
     Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. REEVES GK , Pirie K, Green J, Bull D, et al
     Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis.
     Br J Cancer. 2009;100:538-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. APICELLA C , Peacock SJ, Andrews L, Tucker K, et al
     Measuring, and identifying predictors of, women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. VODERMAIER A , Caspari C, Koehm J, Kahlert S, et al
     Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. DAY JM , Foster PA, Tutill HJ, Newman SP, et al
     BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.
     Br J Cancer. 2009;100:476-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. GADALLA SM , Amr S, Langenberg P, Baumgarten M, et al
     Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. KUO WH , Yen AM, Lee PH, Chen KM, et al
     Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. XU Y , Benlimame N, Su J, He Q, et al
     Regulation of focal adhesion turnover by ErbB signalling in invasive breast cancer cells.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
113. JONES RL , Walsh G, Ashley S, Chua S, et al
     A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer.
     Br J Cancer. 2009;100:305-310.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. TAN EY , Yan M, Campo L, Han C, et al
     The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
     Br J Cancer. 2009;100:405-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. KING M , Jones L, McCarthy O, Rogers M, et al
     Development and pilot evaluation of a complex intervention to improve experienced continuity of care in patients with cancer.
     Br J Cancer. 2009;100:274-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. VAN NES JG , Smit VT, Putter H, Kuppen PJ, et al
     Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. BARNADAS A , Gil M, Gonzalez S, Tusquets I, et al
     Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. KONDO M , Hoshi SL, Toi M
     Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
     Br J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. MILLAR EK , Anderson LR, McNeil CM, O'Toole SA, et al
     BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.
     Br J Cancer. 2009;100:123-33.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: